It has previously been demonstrated that oCRF and the CRF binding protein inhibitor CRF (6-33) reduce body-weight gain in obese Zucker rats. We investigated whether the reduction in body-weight is attributable to altered feeding and drinking behaviour. Obese Zucker rats were ®tted with osmotic mini-pumps connected to i.c.v. cannulas. Vehicle, oCRF (5 m mgaday) or CRF (6-33) (25 m mgaday) were infused for 7 days and the animals observed for an additional 7 days. Body-weight and food and water-intake were recorded daily at 14.00 h. In agreement with published results, oCRF and CRF (6-33) signi®cantly reduced body-weight gain in the obese Zucker rat. In addition, food intake was reduced, whereas water consumption was unaffected.
Introduction
Numerous studies have shown that corticotropin releasing factor (CRF) reduces appetite and promotes loss of body-weight. 1 CRF binds with high af®nity to a binding protein (CRF-BP). Fragments of CRF (such as CRF (6-33)) compete with CRF for the binding protein, and have successfully been used to elevate the levels of free CRF in vitro.
2 Brain CRF dysregulation is suggested to contribute to the pathogenesis of obesity in the Zucker rat; administration of CRF (6-33) will reduce weight gain in obese but not lean Zucker rats. 3 The reduction in body-weight after CRF administration is explained by reduced appetite and increased energy-expenditure. However, the elevation in coretemperature induced by CRF (6-33) in the obese Zucker rat is diminutive, and not likely to be the main cause of the reduction in body-weight gain. Hence altered feeding andaor drinking behaviour must precede the reduction in body-weight seen after administration of CRF (6-33). Indeed, CRF is a potent anorectic agent, and it has already been demonstrated that thirst alters the expression of CRF, 4 and that AVP enhances its release. 5 For this reason, we decided to investigate the effect of CRF and CRF (6-33) on both these parameters.
Experimental methods
Male Zucker rats (lean animals, body-weight 410 AE 10 g; obese animals, body-weight 600 AE 15 g at the onset of the experiment) were ®tted with subcutaneous osmotic mini-pumps (Alzet minipump, model no. 2001). The outlet of the osmotic pump was connected to a brain infusion kit (Alzet), which allowed peptide to be continously infused i.c.v. Vehicle, ovine CRF (oCRF) (5 mgaday) or CRF (6-33) (25 mgaday) was infused for 7 days and the animals (n 6 ± 7 animals per treatment) observed for an additional 7 days. Bodyweight and food-and waterintake were recorded daily at 14.00 h. At the end of the experiment, the animals were sacri®ced and the cannula placements veri®ed.
Results

Obese animals
In agreement with published results, oCRF and CRF (6-33) had signi®cantly reduced body weight gain, compared to vehicle, by the end of the infusion period in the obese animals, by 23% and 11% respectively (Figure 1 ). In addition, food intake was reduced 50% by oCRF and 20% by CRF (6-33) (Figure 2 ). Daily water intake was not affected (Figure 2) . The animals began to regain weight after the end of the infusion period (Figure 1 ).
Lean animals
oCRF reduced body-weight gain in the lean animals by 11% (Figure 2) , while the food intake was reduced 30% (not shown). CRF (6-33) did not have any signi®cant effects on body-weight gain or foodintake. Neither peptide affected the daily water consumption. Similar to the obese animals, the lean animals regained weight after the end of the infusion period ( Figure 1 ).
Discussion
Our results verify and extend previous investigations in that we clearly demonstrate that the reduction in body weight gain is mainly a result of reduced food intake. Our experiments do not measure energy expenditure, and it is possible that part of the weight-loss is due to an increase in energy expenditure. Body-weight is easily in¯uenced by drinking, but we could not measure any effect on water consumption in our study. Hence, we conclude that the reduction in weight-gain by i.c.v. administration of oCRF and CRF (6-33) to the obese male Zucker rat mainly is obtained by a reduction in food intake and that water intake is not affected. Figure 2 In the obese Zucker rat, i.c.v. infusion of oCRF and CRF (6-33) reduced body-weight and food intake, whereas water-intake was unaffected. Figure 1 oCRF reduced body-weight gain in lean and obese Zucker rats, while CRF (6-33) only reduced body-weight gain in the obese Zucker rat.
